Insider Transactions in Q1 2021 at Dicerna Pharmaceuticals Inc (DRNA)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
4,431
-95.98%
|
$128,499
$29.2 P/Share
|
|
Mar 01
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,431
+50.0%
|
$53,172
$12.93 P/Share
|
|
Mar 01
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
8,312
-14.38%
|
$241,048
$29.2 P/Share
|
|
Mar 01
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,312
+21.79%
|
$74,808
$9.09 P/Share
|
|
Feb 05
2021
|
James B Weissman Chief Operating Officer & EVP |
SELL
Open market or private sale
|
Direct |
7,156
-25.5%
|
$186,056
$26.99 P/Share
|
|
Feb 03
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
8,312
-27.87%
|
$207,800
$25.0 P/Share
|
|
Feb 03
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,312
+21.79%
|
$74,808
$9.09 P/Share
|
|
Feb 02
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
4,431
-100.0%
|
$106,344
$24.0 P/Share
|
|
Feb 02
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,431
+50.0%
|
$53,172
$12.93 P/Share
|
|
Jan 25
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
6,326
-100.0%
|
$158,150
$25.0 P/Share
|
|
Jan 25
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,431
+41.19%
|
$53,172
$12.93 P/Share
|
|
Jan 25
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
21,630
-50.13%
|
$540,750
$25.0 P/Share
|
|
Jan 25
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
16,630
+27.82%
|
$149,670
$9.09 P/Share
|
|
Jan 12
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
5,808
-17.97%
|
$139,392
$24.07 P/Share
|
|
Jan 12
2021
|
James B Weissman Chief Operating Officer & EVP |
SELL
Open market or private sale
|
Direct |
5,808
-17.15%
|
$139,392
$24.08 P/Share
|
|
Jan 11
2021
|
James B Weissman Chief Operating Officer & EVP |
SELL
Open market or private sale
|
Direct |
3,800
-10.09%
|
$87,400
$23.99 P/Share
|
|
Jan 08
2021
|
Robert D. Ciappenelli Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,002
-34.67%
|
$46,046
$23.29 P/Share
|
|
Jan 08
2021
|
Robert D. Ciappenelli Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,775
+50.0%
|
-
|
|
Jan 08
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
2,842
-8.08%
|
$65,366
$23.29 P/Share
|
|
Jan 08
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,650
+19.74%
|
-
|
|
Jan 08
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,005
-34.66%
|
$23,115
$23.29 P/Share
|
|
Jan 08
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,900
+50.0%
|
-
|
|
Jan 08
2021
|
Douglas Fambrough Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,159
-14.26%
|
$141,657
$23.29 P/Share
|
|
Jan 08
2021
|
Douglas Fambrough Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,950
+31.6%
|
-
|
|
Jan 08
2021
|
James B Weissman Chief Operating Officer & EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
2,842
-7.02%
|
$65,366
$23.29 P/Share
|
|
Jan 08
2021
|
James B Weissman Chief Operating Officer & EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
8,650
+17.6%
|
-
|